• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Reagents and consumables – Market size and forecast 2019-2024
o Immunodiagnostic systems – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Oncology and endocrinology – Market size and forecast 2019-2024
o Hepatitis and retrovirus – Market size and forecast 2019-2024
o Infectious disease – Market size and forecast 2019-2024
o GI stool – Market size and forecast 2019-2024
o Other applications – Market size and forecast 2019-2024
o Market opportunity by Application
• Market Segmentation by End-user
o Market segmentation by End-user
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o bioMérieux SA
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o OraSure Technologies Inc.
o Quest Diagnostics Inc.
o Siemens AG
o Sysmex Corp.
o Tecan Group Ltd.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ billion)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: Product – Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Reagents and consumables – Market size and forecast 2019-2024 ($ billion)
• 25: Reagents and consumables – Year-over-year growth 2019-2024 (%)
• 26: Immunodiagnostic systems – Market size and forecast 2019-2024 ($ billion)
• 27: Immunodiagnostic systems – Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: Application – Market share 2019-2024 (%)
• 30: Comparison by Application
• 31: Oncology and endocrinology – Market size and forecast 2019-2024 ($ billion)
• 32: Oncology and endocrinology – Year-over-year growth 2019-2024 (%)
• 33: Hepatitis and retrovirus – Market size and forecast 2019-2024 ($ billion)
• 34: Hepatitis and retrovirus – Year-over-year growth 2019-2024 (%)
• 35: Infectious disease – Market size and forecast 2019-2024 ($ billion)
• 36: Infectious disease – Year-over-year growth 2019-2024 (%)
• 37: GI stool – Market size and forecast 2019-2024 ($ billion)
• 38: GI stool – Year-over-year growth 2019-2024 (%)
• 39: Other applications – Market size and forecast 2019-2024 ($ billion)
• 40: Other applications – Year-over-year growth 2019-2024 (%)
• 41: Market opportunity by Application
• 42: Customer landscape
• 43: Market share by geography 2019-2024 (%)
• 44: Geographic comparison
• 45: North America – Market size and forecast 2019-2024 ($ billion)
• 46: North America – Year-over-year growth 2019-2024 (%)
• 47: Europe – Market size and forecast 2019-2024 ($ billion)
• 48: Europe – Year-over-year growth 2019-2024 (%)
• 49: Asia – Market size and forecast 2019-2024 ($ billion)
• 50: Asia – Year-over-year growth 2019-2024 (%)
• 51: ROW – Market size and forecast 2019-2024 ($ billion)
• 52: ROW – Year-over-year growth 2019-2024 (%)
• 53: Key leading countries
• 54: Market opportunity by geography ($ billion)
• 55: Impact of drivers and challenges
• 56: Vendor landscape
• 57: Landscape disruption
• 58: Industry risks
• 59: Vendors covered
• 60: Market positioning of vendors
• 61: Abbott Laboratories – Overview
• 62: Abbott Laboratories – Business segments
• 63: Abbott Laboratories – Key offerings
• 64: Abbott Laboratories – Key customers
• 65: Abbott Laboratories – Segment focus
• 66: bioMérieux SA – Overview
• 67: bioMérieux SA – Business segments
• 68: bioMérieux SA – Key offerings
• 69: bioMérieux SA – Key customers
• 70: bioMérieux SA – Segment focus
• 71: Danaher Corp. – Overview
• 72: Danaher Corp. – Business segments
• 73: Danaher Corp. – Key offerings
• 74: Danaher Corp. – Key customers
• 75: Danaher Corp. – Segment focus
• 76: F. Hoffmann-La Roche Ltd. – Overview
• 77: F. Hoffmann-La Roche Ltd. – Business segments
• 78: F. Hoffmann-La Roche Ltd. – Key offerings
• 79: F. Hoffmann-La Roche Ltd. – Key customers
• 80: F. Hoffmann-La Roche Ltd. – Segment focus
• 81: OraSure Technologies Inc. – Overview
• 82: OraSure Technologies Inc. – Business segments
• 83: OraSure Technologies Inc. – Key offerings
• 84: OraSure Technologies Inc. – Key customers
• 85: OraSure Technologies Inc. – Segment focus
• 86: Quest Diagnostics Inc. – Overview
• 87: Quest Diagnostics Inc. – Business segments
• 88: Quest Diagnostics Inc. – Key offerings
• 89: Quest Diagnostics Inc. – Key customers
• 90: Quest Diagnostics Inc. – Segment focus
• 91: Siemens AG – Overview
• 92: Siemens AG – Business segments
• 93: Siemens AG – Key offerings
• 94: Siemens AG – Key customers
• 95: Siemens AG – Segment focus
• 96: Sysmex Corp. – Overview
• 97: Sysmex Corp. – Business segments
• 98: Sysmex Corp. – Key offerings
• 99: Sysmex Corp. – Key customers
• 100: Sysmex Corp. – Segment focus
• 101: Tecan Group Ltd. – Overview
• 102: Tecan Group Ltd. – Business segments
• 103: Tecan Group Ltd. – Key offerings
• 104: Tecan Group Ltd. – Key customers
• 105: Tecan Group Ltd. – Segment focus
• 106: Thermo Fisher Scientific Inc. – Overview
• 107: Thermo Fisher Scientific Inc. – Business segments
• 108: Thermo Fisher Scientific Inc. – Key offerings
• 109: Thermo Fisher Scientific Inc. – Key customers
• 110: Thermo Fisher Scientific Inc. – Segment focus
• 111: Currency conversion rates for US$
• 112: Research Methodology
• 113: Validation techniques employed for market sizing
• 114: Information sources
• 115: List of abbreviations
【掲載企業】
Abbott Laboratories, bioMérieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics Inc., Siemens AG, Sysmex Corp., Tecan Group Ltd., Thermo Fisher Scientific Inc.
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。